Related Experiment Video

Updated: Jun 9, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Increasing aspirin use among persons at risk for cardiovascular events in Oklahoma

Sue Mallonee, Carrie G Daniels, James W Mold

    The Journal of the Oklahoma State Medical Association
    |September 9, 2010
    PubMed

    Insights

    Low-dose aspirin is underutilized for preventing cardiovascular disease (CVD) in Oklahoma, despite recommendations. Patient counseling by health professionals significantly increases aspirin use for CVD prevention.

    Area of Science:

    • Public Health
    • Cardiology
    • Preventive Medicine

    Background:

    • Cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke, is the leading cause of death in the US and Oklahoma.
    • Oklahoma faces a high CVD mortality rate, ranking 48th nationally.
    • This study examines Oklahoma-specific CVD data and aspirin use recommendations.

    Purpose of the Study:

    • To present Oklahoma-specific data on cardiovascular disease (CVD) prevalence and risk factors.
    • To review current recommendations for aspirin use in CVD event prevention.
    • To assess aspirin utilization and identify barriers in Oklahoma.

    Main Methods:

    • Calculated average annual age-adjusted death rates for CVD.
    • Utilized Oklahoma Behavioral Risk Factor Surveillance System (BRFSS) data for CHD history, risk factors, and aspirin use in adults 45+.
    • Conducted a literature review of aspirin use guidelines for CVD prevention.

    Main Results:

    • Between 2005-2008, 14.8% of Oklahomans 45+ had CHD history, 6.4% had stroke history.
    • High prevalence of risk factors: 50% hypertension/hypercholesterolemia, 21.5% smokers, 16.0% diabetes.
    • Despite recommendations, aspirin use was 44-57% among at-risk individuals; only 79% took aspirin if counseled vs. 18% if not.

    Conclusions:

    • Low-dose aspirin is underutilized in Oklahoma for CVD event and death reduction.
    • Healthcare professional counseling is crucial for increasing appropriate aspirin use.
    • Community-based interventions show promise in promoting aspirin use.
    Abstract

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Drug toxicity: Drug–Drug Interaction01:30

    Drug toxicity: Drug–Drug Interaction

    Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    Atherosclerosis IV: Nursing Management01:23

    Atherosclerosis IV: Nursing Management

    Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
    Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

    Acute Kidney Injury IV: Diagnostic Studies and Prevention

    Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...